Kyowa Kirin, Inc.
36 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma (NCT07192471) | Kyowa Kirin, Inc. | 2026-08-01 |
| Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches. (NCT05027646) | Kyowa Kirin, Inc. | 2021-07-06 |
| Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite (NCT04190654) | Kyowa Kirin, Inc. | 2019-11-26 |
| KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer (NCT03915405) | Kyowa Kirin, Inc. | 2019-09-26 |
| Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab (NCT04014374) | Kyowa Kirin, Inc. | 2019-09-10 |
| Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356 (NCT04147910) | Kyowa Kirin, Inc. | 2019-08-21 |
| Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis (NCT03703102) | Kyowa Kirin, Inc. | 2018-10-22 |
Track Kyowa Kirin, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.